A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

ADA Makes Financial Investment in Two Technology Companies


The American Dental Association (ADA) has invested in two innovative companies, Oral Genome and Overjet, which offer cutting-edge technologies to support oral health professionals in diagnosis and patient care. Oral Genome developed a saliva test that detects biomarkers related to caries and periodontitis, providing instant results through a mobile app, while Overjet’s artificial intelligence platform enables real-time detection of dental caries and bone loss from radiographs. These investments were made through the ADA Innovation Advisory Committee, which evaluates products and technologies from a financial standpoint. While not an endorsement of the products, these investments aim to support the future financial success of the ADA. They also represent a commitment to advancing dental care and integrating technology to benefit both providers and patients alike. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy